Author:
Alexandrino Eduardo Gauze,Meller Fernanda Oliveira,Meucci Rodrigo Dalke,Da Silva Priscila Arruda,Schäfer Antônio Augusto,Dumith Samuel Carvalho
Abstract
The first recommendations to prevent coronavirus disease 2019 (COVID-19) were made without epidemiological information on what would be people’s behaviors in view of the biopsychosocial and physical effects of confinement because of a health emergency with great economic impact. Objective: To determine the incidence of COVID-19; analyze the associated behavioral and sociodemographic factors. Methods: Cross-sectional population-based study with a representative sample of two cities in southern Brazil. 2,170 individuals aged 18 years or over were interviewed from October 2020 to January 2021. Data were collected in person at the place of residence of the individuals using a questionnaire. Results: The incidence of COVID-19 was 6.8% (95% confidence interval, CI: 5.4; 8.4), and was significantly higher in white people, aged between 18 and 59 years, married, with higher education, higher family income, and who lived in an apartment. The incidence of COVID-19 was associated with diabetes. People who stayed less time at home has a higher incidence (3.7% versus 7.5%). The most reported symptoms were excessive tiredness, reduced smell and taste. Most of the individuals (85%) sought a health facility and less than 5% were hospitalized. Conclusion: Almost one in ten individuals was infected by COVID-19. The incidence was higher for adults (because of being more exposed), individuals from higher socioeconomic level (because of having tested more) and in diabetics. Almost everyone stayed home after being diagnosed with the virus, and the main risk factor was having contact with someone infected.
Publisher
South Florida Publishing LLC
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science
Reference54 articles.
1. World Health Organization. Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operation Update. World Health Organisation; 2020-1. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed in 2021 (Sep 30).
2. The Lancet Respiratory Medicine. COVID-19: delay, mitigate, and communicate. Lancet Respir Med. 2020; 8(4):321. PMID: 32192583; https://doi.org/10.1016/S2213-2600(20)30128-4.
3. Aquino EML, Silveira IH, Pescarini JM, et al. Social distancing measures to control the COVID-19 pandemic: Potential impacts and challenges in Brazil. Cienc Saude Colet. 2020;25 (suppl l):2423–46; PMID: 32520287; https://doi.org/10.1590/1413-81232020256.1.10502020.
4. Centers for disease control and prevention. CDC 24/7: Saving Lives, Protecting People. People with Certain Medical Conditions; 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. Accessed in 2021 (Sep 20).
5. Word Health Organization (WHO). Advice for the Public Sector. Coronavirus Dis advice public. 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public. Accessed in 2021 (Sep 30).